(Q28373075)

2

0 references

R E Richner

3

0 references

M B Fowler

4

0 references

G Oster

American Journal of Cardiology

5

0 references

language of work or name

English

0 references

publication date

15 March 1999

0 references

published in

0 references

volume

83

0 references

issue

6

0 references

page(s)

890-6

0 references

cites work

Effects of beta-adrenergic blockade on survival of patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

The role of beta-blockers in left ventricular dysfunction and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

Effects of beta blockers on symptoms and functional capacity in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

Markov models in medical decision making: a practical guide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

The sequelae of hospitalization for congestive heart failure among older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

Results of the economic evaluation of the first study. A multinational prospective economic evaluation. FIRST Investigators. Flolan International Randomized Survival Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

Beta-adrenergic blockers and survival in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2901066-2

10.1016/S0002-9149(98)01066-2

7 January 2021

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

10190405

1 reference

Consolidated OpenCitations Corpus – April 2017